{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-005030","form_type":"8-K","ticker":"OCGN","cik":"0001372299","company_name":"Ocugen, Inc.","filed_at":"2025-02-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.458167+00:00","generated_at":"2026-05-26T22:46:26.115499+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"low","headline":"Ocugen posts clinical presentation showing 84% reduction in mean total atrophy area in treated group","bullets":["Presentation reports mean change in total atrophy area from baseline: 0.12±0.36 mm² (treated) vs 0.73±0.26 mm² (untreated), an 84% difference.","A 44% efficacy metric also cited; specific endpoint not fully legible from exhibit.","Presentation posted on website and may be used in investor discussions; no formal press release or guidance provided."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-005030","json":"https://secwatch.observer/filing/0001628280-25-005030.json","markdown":"https://secwatch.observer/filing/0001628280-25-005030.md","text":"https://secwatch.observer/filing/0001628280-25-005030.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1372299/000162828025005030/0001628280-25-005030-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1372299/000162828025005030/ocgn-20250212.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T22:46:26.115499+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}